UK-based men's health startup Numan has raised £14.7 million or $20 million from Keros Capital as debt. This completes their Series B funding round to total £44.3 million. The funding round was led by White Star Capital along with Novator, VNV Global and Anthemis Exponential. This round puts Numan’s total funds raised in 5 rounds to be around $72.9 million.

Founded by Sokratis Papafloratos in 2018, Numan offers many services that cater to men’s health. It includes services like treatments for hair loss, erectile dysfunction, premature ejaculation, nutritional deficiencies, sexual health, gut and lung health. They have an AI-powered symptom checker that provides its analysis to medical professionals. They also provide at-home blood testing, health advice and direct-to-consumer health products

Since its inception, the company has helped thousands of men across the UK and have grown their business organically via two strategic acquisitions in the UK and Sweden. Last year, the venture acquired the Swedish medical science and healthcare technology company Vi-Health. Along with the funding they have also announced Numan’s blood testing proposition in the UK. This promoted men to fearlessly test their blood to understand their health better.